SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001047469-18-006698
Filing Date
2018-10-12
Accepted
2018-10-12 16:03:11
Documents
4
Period of Report
2018-12-12

Document Format Files

Seq Description Document Type Size
1 PRE 14A a2236896zpre14a.htm PRE 14A 478369
2 G365892BCI001.JPG g365892bci001.jpg GRAPHIC 119502
3 G365892BCI002.JPG g365892bci002.jpg GRAPHIC 111785
4 G111573.JPG g111573.jpg GRAPHIC 5681
  Complete submission text file 0001047469-18-006698.txt   806081
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37467 | Film No.: 181120265
SIC: 2834 Pharmaceutical Preparations